Bihar achieves historic first in lymphatic filariasis elimination

For generations, families across Bihar have lived under the burden of lymphatic filariasis (LF), a preventable neglected tropical disease that can cause lifelong disability, social stigma, and economic hardship. For the first time since launching Mass Drug Administration (MDA) in 2004, Bihar has successfully cleared its first Transmission Assessment Survey (TAS)—the standardized survey used to determine whether LF transmission has fallen below levels required to prevent new infection. Passing TAS allows the national programme to stop MDA and transition to post-MDA surveillance.

The achievement is significant not only for Bihar but also for India’s goal of eliminating LF as a public health problem by 2027. As of May 2026, LF is endemic in 350 districts across 20 states and union territories in India. Bihar has faced one of the toughest challenges: all 38 districts and 592 implementation units are endemic for the disease.

This year, four districts—Araria, Madhepura, Supaul and Kishanganj—became the first in Bihar to undertake TAS 1 after meeting stringent eligibility requirements, including multiple effective rounds of MDA, high treatment coverage, and successful pre-assessment surveys. The results marked a watershed moment. Of the 57 implementation units assessed, 55 successfully cleared TAS 1. All implementation units in Araria, Madhepura and Supaul passed, enabling these districts to stop MDA. Two implementing units in Kishanganj narrowly missed the required threshold.

The breakthrough was the result of several years of focused improvements in programme quality. A key shift was Bihar’s renewed emphasis on Directly Observed Treatment (DOT), which ensures that medicines are consumed in the presence of trained health workers rather than simply distributed. This addressed a longstanding challenge in LF elimination programmes: translating medicine distribution into actual treatment coverage.

The approach transformed implementation on the ground. Frontline workers spent more time engaging with families, answering questions, dispelling misconceptions and encouraging compliance. Monitoring systems were strengthened, and field teams used real-time findings to improve campaign performance. These efforts led to steadily increasing treatment coverage and, ultimately, measurable reductions in disease transmission. “After years of consistent effort, this achievement shows that quality implementation makes the difference,” says the District Vector Borne Disease Officer in Araria. “Our teams ensured not just distribution, but consumption, and today we are seeing the results.”

Community trust was equally critical to success. Health workers invested time in explaining the benefits of treatment, addressing fears about side effects, and building confidence in the programme. These efforts helped overcome hesitation that had often limited participation in previous rounds of MDA. “Earlier, people were unsure about the medicines. This time, health workers stayed with us and explained everything. Now we feel protected and hopeful that this disease will not affect our children,” said a parent whose child participated in school-based testing during TAS.

Bihar’s progress also highlights the growing strength of its frontline health workforce. Community Health Officers (CHOs) played an important role during TAS implementation. In areas with limited laboratory personnel, trained CHOs conducted LF testing with high accuracy and very few invalid results, a critical part of Bihar’s elimination effort. Their contribution demonstrates how investments in frontline capacity can strengthen surveillance systems and improve programme outcomes.

WHO assisted the programme led by the Government of Bihar and the National Centre for Vector Borne Diseases Control (NCVBDC) throughout this journey. During MDA campaigns, WHO supported state and district teams in microplanning, training, independent monitoring and corrective actions based on field findings. During TAS, WHO also supported survey planning, quality assurance, training of laboratory personnel and CHOs, and deployment of monitoring teams across all evaluation units.

This sustained partnership helped ensure that improvements in programme implementation translated into measurable reductions in transmission. Continued surveillance will be essential to sustain gains and achieve complete elimination.

Bihar’s experience demonstrates that even deeply entrenched public health challenges can be overcome through persistence, strong systems, community trust and a relentless focus on quality. Every district that moves closer to elimination represents children protected from a disease that can cause lifelong disability, families spared healthcare costs and lost income, and communities freed from a condition that has long reinforced poverty and exclusion.

This story has been adapted from WHO story